UBS lowered the firm’s price target on Dentsply Sirona (XRAY) to $23 from $24 and keeps a Buy rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona price target lowered to $15 from $17 at BofA
- Closing Bell Movers: BrightSpring Health up 6% on S&P 600 inclusion
- Dentsply Sirona says SEC will not recommend any action against company
- DENTSPLY SIRONA SEC Investigation Concludes Favorably
- Dentsply Sirona price target lowered to $13 from $17 at Evercore ISI